CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2022			145,565,916
Beginning balance at Dec. 31, 2022	$ 385,941	$ 11,483	$ 15	$ 1,226,267	$ (840,341)	$ 11,483
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			590,831
Stock-based compensation, net of tax withholding	13,807			13,807
Issuance of common stock, net of offering costs (in shares)			32,305,554
Issuance of common stock, net of offering costs	265,786		$ 3	265,783
Series A Preferred Stock accretion to redemption value	(2,121)			(2,121)
Exchange of convertible notes for common stock (in shares)			31,722,417
Exchange of convertible notes for common stock	318,771		$ 3	318,768
Net income (loss)	109,347				109,347
Ending balance (in shares) at Sep. 30, 2023			210,184,718
Ending balance at Sep. 30, 2023	$ 1,103,014		$ 21	1,822,504	(719,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2023-08 [Member]
Beginning balance (in shares) at Jun. 30, 2023			174,209,038
Beginning balance at Jun. 30, 2023	$ 742,084		$ 17	1,461,188	(719,121)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			70,963
Stock-based compensation, net of tax withholding	5,598			5,598
Issuance of common stock, net of offering costs (in shares)			4,182,300
Issuance of common stock, net of offering costs	36,951		$ 1	36,950
Exchange of convertible notes for common stock (in shares)			31,722,417
Exchange of convertible notes for common stock	318,771		$ 3	318,768
Net income (loss)	(390)				(390)
Ending balance (in shares) at Sep. 30, 2023			210,184,718
Ending balance at Sep. 30, 2023	$ 1,103,014		$ 21	1,822,504	(719,511)
Beginning balance (in shares) at Dec. 31, 2023	242,829,391		242,829,391
Beginning balance at Dec. 31, 2023	$ 1,615,921		$ 24	2,183,537	(567,640)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			4,180,445
Stock-based compensation, net of tax withholding	100,908			100,908
Issuance of common stock, net of offering costs (in shares)			59,449,012
Issuance of common stock, net of offering costs	1,155,004		$ 6	1,154,998
Repurchase of shares in settlement of restricted stock (in shares)			(1,546,102)
Repurchase of shares in settlement of restricted stock	(28,965)			(28,965)
Net income (loss)	$ 12,725				12,725
Ending balance (in shares) at Sep. 30, 2024	304,912,746		304,912,746
Ending balance at Sep. 30, 2024	$ 2,855,593		$ 30	3,410,478	(554,915)
Beginning balance (in shares) at Jun. 30, 2024			287,046,579
Beginning balance at Jun. 30, 2024	2,642,655		$ 28	3,072,753	(430,126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			859,452
Stock-based compensation, net of tax withholding	22,818			22,818
Issuance of common stock, net of offering costs (in shares)			17,313,059
Issuance of common stock, net of offering costs	320,761		$ 2	320,759
Repurchase of shares in settlement of restricted stock (in shares)			(306,344)
Repurchase of shares in settlement of restricted stock	(5,852)			(5,852)
Net income (loss)	$ (124,789)				(124,789)
Ending balance (in shares) at Sep. 30, 2024	304,912,746		304,912,746
Ending balance at Sep. 30, 2024	$ 2,855,593		$ 30	$ 3,410,478	$ (554,915)